Skip to main content

Peer Review reports

From: Histone deacetylase inhibitor panobinostat induces antitumor activity in epithelioid sarcoma and rhabdoid tumor by growth factor receptor modulation

Original Submission
18 Dec 2020 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
22 Mar 2021 Reviewed Reviewer Report - Akihiro Ito
28 Apr 2021 Reviewed Reviewer Report
30 Apr 2021 Reviewed Reviewer Report - Jyoti Bajpai
20 May 2021 Author responded Author comments - Birgit Geoerger
Resubmission - Version 3
20 May 2021 Submitted Manuscript version 3
21 May 2021 Author responded Author comments - Birgit Geoerger
Resubmission - Version 4
21 May 2021 Submitted Manuscript version 4
22 May 2021 Author responded Author comments - Birgit Geoerger
Resubmission - Version 5
22 May 2021 Submitted Manuscript version 5
8 Jun 2021 Reviewed Reviewer Report - Jyoti Bajpai
9 Jun 2021 Reviewed Reviewer Report - Akihiro Ito
21 Jun 2021 Reviewed Reviewer Report
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
10 Jul 2021 Editorially accepted
20 Jul 2021 Article published 10.1186/s12885-021-08579-w

You can find further information about peer review here.

Back to article page